Acyl dihydropyrazolo[1,5-a]pyrimidinones as metabotropic glutamate receptor 5 positive allosteric modulators

被引:5
|
作者
Malosh, Chrysa [1 ,2 ,3 ,4 ]
Turlington, Mark [1 ,2 ,3 ,4 ]
Bridges, Thomas M. [1 ,2 ,3 ]
Rook, Jerri M. [1 ,2 ,3 ]
Noetzel, Meredith J. [1 ,2 ,3 ]
Vinson, Paige N. [1 ,2 ,3 ]
Steckler, Thomas [5 ]
Lavreysen, Hilde [5 ]
Mackie, Claire [6 ]
Bartolome-Nebreda, Jose M. [7 ]
Conde-Ceide, Susana [7 ]
Martinez-Viturro, Carlos M. [7 ]
Piedrafita, Maria [7 ]
Sanchez-Casado, M. Rosa [7 ]
Macdonald, Gregor J. [5 ]
Daniels, J. Scott [1 ,2 ,3 ]
Jones, Carrie K. [1 ,2 ,3 ]
Niswender, Colleen M. [1 ,2 ,3 ]
Conn, P. Jeffrey [1 ,2 ,3 ]
Lindsley, Craig W. [1 ,2 ,3 ,4 ]
Stauffer, Shaun R. [1 ,2 ,3 ,4 ]
机构
[1] Vanderbilt Univ, Dept Pharmacol, Med Ctr, Nashville, TN 37232 USA
[2] Vanderbilt Univ, Vanderbilt Ctr Neurosci Drug Discovery, Med Ctr, Nashville, TN 37232 USA
[3] Vanderbilt Specialized Chem Ctr Probe Dev MLPCN, Nashville, TN 37232 USA
[4] Vanderbilt Univ, Dept Chem, Nashville, TN 37232 USA
[5] Janssen Res & Dev, Neurosci, B-2340 Beerse, Belgium
[6] Janssen Res & Dev, Discovery Sci ADME Tox, Toledo 45007, Spain
[7] Janssen Res & Dev, Neurosci Med Chem, Toledo 45007, Spain
关键词
Metabotropic glutamate receptor 5 (mGlu(5)); Positive allosteric modulator (PAM); NMDA-RECEPTOR; DISCOVERY; SERIES; SAR;
D O I
10.1016/j.bmcl.2015.10.009
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We report the optimization of a series of metabotropic glutamate receptor 5 (mGlu(5)) positive allosteric modulators (PAMs) from an acyl dihydropyrazolo[1,5-a]pyrimidinone class. Investigation of exocyclic amide transpositions with this unique 5,6-bicyclic core were conducted in attempt to modulate physicochemical properties and identify a suitable backup candidate with a reduced half-life. A potent and selective PAM, 1-(2-(phenoxymethyl)-6,7-dihydropyrazolo[1,5-a]pyrimidin-4(5H)-yl) ethanone (9a, VU0462807), was identified with superior solubility and efficacy in the acute amphetamine-induced hyperlocomotion (AHL) rat model with a minimum effective dose of 3 mg/kg. Attempts to mitigate oxidative metabolism of the western phenoxy of 9a through extensive modification and profiling are described. (C) 2015 Elsevier Ltd. All rights reserved.
引用
收藏
页码:5115 / 5120
页数:6
相关论文
共 50 条
  • [11] Tetrahydronaphthyridine and Dihydronaphthyridinone Ethers As Positive Allosteric Modulators of the Metabotropic Glutamate Receptor 5 (mGlu5)
    Turlington, Mark
    Malosh, Chrysa
    Jacobs, Jon
    Manka, Jason T.
    Noetzel, Meredith J.
    Vinson, Paige N.
    Jadhav, Satyawan
    Herman, Elizabeth J.
    Lavreysen, Hilde
    Mackie, Claire
    Bartolome-Nebreda, Jose M.
    Conde-Ceide, Susana
    Luz Martin-Martin, M.
    Min Tong, Han
    Lopez, Silvia
    MacDonald, Gregor J.
    Steckler, Thomas
    Daniels, J. Scott
    Weaver, C. David
    Niswender, Colleen M.
    Jones, Carrie K.
    Conn, P. Jeffrey
    Lindsley, Craig W.
    Stauffer, Shaun R.
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (13) : 5620 - 5637
  • [12] Positive Allosteric Modulators of Metabotropic Glutamate Receptor 5 as Tool Compounds to Study Signaling Bias
    Arsova, Angela
    Moller, Thor C.
    Hellyer, Shane D.
    Vedel, Line
    Foster, Simon R.
    Hansen, Jakob L.
    Brauner-Osborne, Hans
    Gregory, Karen J.
    MOLECULAR PHARMACOLOGY, 2021, 99 (05) : 328 - 341
  • [13] Pharmacological characterisation of positive allosteric modulators acting on the metabotropic glutamate receptor 2
    Bennett, K. A.
    Weaver, A.
    Marshall, F.
    Langmead, C. J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2013, 23 : S4 - S5
  • [15] Positive allosteric modulators of metabotropic glutamate 1 receptor: Characterization, mechanism of action, and binding site
    Knoflach, F
    Mutel, V
    Kew, JNC
    Malherbe, P
    Vieira, E
    Wichmann, J
    Kemp, JA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (23) : 13402 - 13407
  • [16] Tricyclic Thiazolopyrazole Derivatives as Metabotropic Glutamate Receptor 4 Positive Allosteric Modulators
    Hong, Sang-Phyo
    Liu, Kevin G.
    Ma, Gil
    Sabio, Michael
    Uberti, Michelle A.
    Bacolod, Maria D.
    Peterson, John
    Zou, Zack Z.
    Robichaud, Albert J.
    Doller, Dario
    JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (14) : 5070 - 5081
  • [17] Pharmacological and molecular characterization of the positive allosteric modulators of metabotropic glutamate receptor 2
    Lundstrom, L.
    Bissantz, C.
    Beck, J.
    Dellenbach, M.
    Woltering, T. J.
    Wichmann, J.
    Gatti, S.
    NEUROPHARMACOLOGY, 2016, 111 : 253 - 265
  • [18] Positive allosteric modulators of metabotropic glutamate receptor 1: Characterisation and putative binding site.
    Kemp, JA
    Kew, JNC
    Mutel, V
    Jolidon, S
    Malherbe, P
    Vieira, E
    Wichmann, J
    Knoflach, F
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135
  • [19] Dihydrothiazolopyridone Derivatives as a Novel Family of Positive Allosteric Modulators of the Metabotropic Glutamate 5 (mGlwu5) Receptor
    Manuel Bartolome-Nebreda, Jose
    Conde-Ceide, Susana
    Delgado, Francisca
    Iturrino, Laura
    Pastor, Joaquin
    Angel Pena, Miguel
    Trabanco, Andres A.
    Tresadern, Gary
    Wassvik, Carola M.
    Stauffer, Shaun R.
    Jadhav, Satyawan
    Gogi, Kiran
    Vinson, Paige N.
    Noetzel, Meredith J.
    Days, Emily
    Weaver, C. David
    Lindsley, Craig W.
    Niswender, Colleen M.
    Jones, Carrie K.
    Conn, P. Jeffrey
    Rombouts, Frederik
    Lavreysen, Hilde
    Macdonald, Gregor J.
    Mackie, Claire
    Steckler, Thomas
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (18) : 7243 - 7259
  • [20] Positive Allosteric Modulators (PAMs) of Metabotropic Glutamate Receptor 5 (mGluR5) Attenuate Microglial Activation
    Xue, Fengtian
    Stoica, Bogdan A.
    Hanscom, Marie
    Kabadi, Shruti V.
    Faden, Alan I.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2014, 13 (04) : 558 - 566